New Delhi, March 11 A study has found that a woman's risk of developing dementia may be predicted 25 years before symptoms begin through a test of a blood-based biomarker called 'phosphorylated tau 217' – a protein linked to the brain changes seen in Alzheimer's disease.Higher levels of...
alzheimer's disease
apoe e4
biomarker
blood test
cognitive impairment
cognitiveoutcomes
dementia
genetics
hormone therapy
mild cognitive impairment
phosphorylated tau 217
risk prediction
university of california san diego
women's health
women's health initiative memory study